A Physician Advisory System for Chronic Heart Failure Management Based
  on Knowledge Patterns by Chen, Zhuo et al.
ar
X
iv
:1
61
0.
08
11
5v
1 
 [c
s.A
I] 
 25
 O
ct 
20
16
Under consideration for publication in Theory and Practice of Logic Programming 1
A Physician Advisory System for Chronic Heart Failure
Management Based on Knowledge Patterns
Zhuo Chen, Kyle Marple, Elmer Salazar, Gopal Gupta, Lakshman Tamil
University of Texas at Dallas, Texas, U.S.A.
(e-mail: {zxc130130,kbm072000,ees101020,gupta,laxman}@utdallas.edu)
submitted 1 January 2003; revised 1 January 2003; accepted 1 January 2003
Abstract
Management of chronic diseases such as heart failure, diabetes, and chronic obstructive pulmonary disease
(COPD) is a major problem in health care. A standard approach that the medical community has devised
to manage widely prevalent chronic diseases such as chronic heart failure (CHF) is to have a committee of
experts develop guidelines that all physicians should follow. These guidelines typically consist of a series of
complex rules that make recommendations based on a patient’s information. Due to their complexity, often
the guidelines are either ignored or not complied with at all, which can result in poor medical practices. It is
not even clear whether it is humanly possible to follow these guidelines due to their length and complexity.
In the case of CHF management, the guidelines run nearly 80 pages. In this paper we describe a physician-
advisory system for CHF management that codes the entire set of clinical practice guidelines for CHF using
answer set programming. Our approach is based on developing reasoning templates (that we call knowledge
patterns) and using these patterns to systemically code the clinical guidelines for CHF as ASP rules. Use
of the knowledge patterns greatly facilitates the development of our system. Given a patient’s medical
information, our system generates a recommendation for treatment just as a human physician would, using
the guidelines. Our system will work even in the presence of incomplete information. Our work makes
two contributions: (i) it shows that highly complex guidelines can be successfully coded as ASP rules,
and (ii) it develops a series of knowledge patterns that facilitate the coding of knowledge expressed in a
natural language and that can be used for other application domains. This paper is under consideration for
acceptance in TPLP.
KEYWORDS: chronic disease management, chronic heart failure, knowledge pattern, answer set program-
ming, clinical practice guideline, knowledge representation, automated reasoning
1 Introduction
Chronic diseases are health conditions that can neither be prevented nor be cured but can only
be managed. They have been the major consumer of health-care funds throughout the world. In
America alone there are more than 133 million people—which is more than 40% of the U.S.
population—who suffer from one or more chronic diseases (Wu and Green 2000). In the U.S.
they account for 81% of hospital admissions, 91% of prescriptions filled and 76% of all physi-
cian visits (Anderson 2004). Though the list of chronic conditions is long, the top five conditions
are: heart disease, cancers, stroke, chronic obstructive pulmonary disease (COPD) and diabetes.
In 2010, 68% of the healthcare spending—more than trillion dollars—went towards the treatment
of chronic diseases (Centers for Disease Control and Prevention 2016). The successful manage-
ment of chronic diseases has two components: (i) self-management by the patients, and (ii) man-
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agement by physicians while adhering to strict guidelines. The failure of either component will
lead to the failure of the whole enterprise for the management of chronic diseases.
We selected Chronic Heart Failure (CHF) as our first chronic disease to build tools to manage.
Chronic Heart Failure is the inability of the heart to pump properly; consequently, not enough
oxygen-rich blood can be supplied to all parts of the body. This causes congestion of blood in the
lungs, abdomen, legs, etc., causing uneasiness while carrying out any kind of physical activity.
Half of the people diagnosed with CHF die within five years. In U.S. alone there are 5.7 million
people currently living with CHF (Go et al. 2013). This disease affects all age groups including
children. The cost of this disease to the economy is enormous. The statistics show that there are
11 million physician visits and 875,000 hospitalizations per year due to CHF. 25% of patient with
CHF are readmitted to a hospital or visit an emergency room within thirty days of treatment. This
causes hospitals to lose money, as new regulations require them to bear the cost of readmission
if it occurs within a period of thirty days.
Our work on chronic disease management started several years ago with the building of a tele-
medicine-based chronic disease management system designed to facilitate the self-management
of chronic diseases by patients (Monteiro et al. 2011; Monteiro 2015). Our chronic care platform
was put to test to see whether it can successfully prevent patients from going to an emergency
room or being readmitted to a hospital within 30 days of discharge after the original CHF episode.
This was done in collaboration with Texas Health Resources (THR), one of the largest hospital
chains in the southwestern United States. Statistically, 25% of discharged patients would be read-
mitted within 30 days. In our clinical study, 12 patients discharged from Texas Methodist Hospi-
tal in Cleburne, Texas after CHF episodes were chosen as subjects. (Note that though the number
of patients used in the trial is not statistically significant to make any generalization but does
prove the viability of our system). These patients were provided with our chronic care platform
and peripheral devices such as a weighing scale, blood pressure meter, gluco-meter and pulse
oximeter (these devices measure the vitals directly and are connected to our telemedicine device
via Bluetooth). After some training by case nurses, the patients measured their vital signs peri-
odically using these Bluetooth-enabled devices and answered questionnaires about their health.
Using our platform, their vital sign data was automatically uploaded to a server where it was
available for processing and viewing. Working remotely, the case nurse was able to manage the
patients and prevent all of them from begin readmitted within 30 days (Baldwin et al. 2013).
The telemedicine platform that we initially developed, and that we have licensed to a commer-
cial company, only facilitated the transfer of information from patients residing remotely to the
doctors and nurses providing care.
In this paper, we focus on the second component of CHF management, namely, a Physician
Advisory System. This system assists physicians in adhering to the guidelines for managing CHF.
The CHF management guidelines are published by the American College of Cardiology Foun-
dation (ACCF) and the American Heart Association (AHA). The most recent version is the 2013
ACCF/AHA Guideline for the Management of Heart Failure (Yancy et al. 2013). These guide-
lines were created by a committee of physicians based on thorough review of clinical evidence on
heart failure management. They represent a consensus among the physicians on the appropriate
treatment and management of heart failure (Jacobs et al. 2013). Though evidence-based guide-
lines should be the basis for all disease management (Faxon et al. 2004), physicians’ adherence
to guidelines is very poor (Cabana et al. 1999). The major reasons for the failure of guideline
implementation are lack of awareness, lack of familiarity, lack of motivation and external barri-
ers. For 78% of clinical practice guidelines, more than 10% of the physicians are not aware of
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their existence. Even when the guidelines are readily accessible, the physicians are not familiar
enough with the guidelines to apply them correctly. In all the physician surveys conducted, the
lack of familiarity was more common than the lack of awareness (Cabana et al. 1999).
One of the reasons for the lack of familiarity is that the guidelines can be quite complex, as in
the case of CHF management. For example, more than 100 variables have been associated with
mortality and re-hospitalization related to heart failure. In the 2013 ACCF/AHA Guideline for
the Management of Heart Failure, the variables range from simple information like age and sex
to sophisticated data like the patterns in electrocardiogram and history of CHF-related symptoms
and diseases. The rules for treatment recommendation in the guideline look like the following:
“Aldosterone receptor antagonists are recommended to reduce morbidity and mortality following an
acute MI in patients who have LVEF of 40% or less who develop symptoms of HF or who have a
history of diabetes mellitus, unless contraindicated.”
“In patients with a current or recent history of fluid retention, beta blockers should not be prescribed
without diuretics.”
With more than 60 rules like the ones above, giving correct recommendations becomes an
error-prone task for even the most experienced physicians (Group 2006).
To overcome the difficulties that physicians face in implementing the guidelines, we have
developed a Physician Advisory System that automates the 2013 ACCF/AHA Guideline for the
Management of Heart Failure. Our physician advisory system is able to give recommendations
like a real human physician who is following the guidelines strictly, even under the condition of
incomplete information about the patient.
Our physician-advisory system for chronic heart failure management relies on answer set
programming (Gelfond and Lifschitz 1988; Brewka et al. 2011) for coding the guidelines. The
guideline rules are fairly complex and require the use of negation as failure, non-monotonic rea-
soning and reasoning with incomplete information. A fairly common situation in medicine is that
a drug can only be recommended if its use is not contraindicated (i.e., the use of the drug will not
have an adverse impact on that patient). Contraindication is naturally modeled via negation as
failure. The ability of answer set programming to model defaults, exceptions, weak exceptions,
preferences, etc., makes it ideally suited for coding these guidelines. Traditional techniques such
as logic programming (Prolog) and production systems (OPS5), or traditional expert system
styled approaches will result in a far more complex system due to the inability of these systems
to model negation as failure effectively (Baral 2003). For example, in Prolog, negation as failure
is unsound for non-grounded goals, and if care is not taken, then use of negation as failure in
Prolog programs can often lead to non-termination. Thus, coding our system in these formalisms
would be a much more difficult and complex task. In contrast, the CHF guidelines can be coded
in ASP very naturally (it took about 2 months to develop the first version of the system).
With the help of a telemedicine platform (Baldwin et al. 2013) and electronic medical records
(EMR) integrated with our ASP-based system, significant automation can be achieved. Besides
boosting the physicians’ compliance with the guidelines, the system can enable patients with
CHF to manage their conditions with minimal supervision by doctors. The rest of this paper
presents our ASP-based physician-advisory system as well as the knowledge patterns we have
developed. We assume that the reader is familiar with ASP (Brewka et al. 2011).
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2 Automating Chronic Heart Failure Management
The 2013 ACCF/AHA Guideline for the Management of Heart Failure is intended to assist
healthcare providers in clinical decision making by describing a range of generally acceptable ap-
proaches for the management of chronic heart failure. The guideline is based on four progressive
stages of heart failure. Stage A includes patients at risk of heart failure who are asymptomatic
and do not have structural heart disease. Stage B describes asymptomatic patients with structural
heart diseases; it includes New York Heart Association (NYHA) class I, in which ordinary phys-
ical activity does not cause symptoms of heart failure. Stage C describes patients with structural
heart disease who have prior or current symptoms of heart failure; it includes NYHA class I, II
(slight limitation of physical activity), III (marked limitation of physical activity) and IV (unable
to carry on any physical activity without symptoms of heart failure, or symptoms of heart failure
at rest). Stage D describes patients with refractory heart failure who require specialized interven-
tions; it includes NYHA class IV. Interventions at each stage are aimed at reducing risk factors
(stage A), treating structural heart disease (stage B) and reducing morbidity and mortality (stages
C and D) (Yancy et al. 2013).
The input to the system is a patient’s information, including demographics, history, daily
symptoms, risks and measurements, as well as ACCF/AHA stage and NYHA class. When queried
for a treatment recommendation, our system is able to give recommendations according to the
guideline just as a physician would.
Our system is designed for running on top of the s(ASP) system, a goal-directed, predi-
cate ASP system that can be thought of as Prolog extended with negation based on the sta-
ble model semantics (Marple et al. 2016). Because of the goal-directed nature of the system,
only the particular treatments applicable to the patient are reported by the system. With mi-
nor changes, our system will also work with traditional SAT-based implementations such as
CLASP (Gebser et al. 2012; Gebser et al. 2014). However, these systems will compute the en-
tire model, so if there are multiple treatments for a given condition, they will all be included in
the answer set (these differences between goal-directed and SAT-based solvers are explained in
(Marple & Gupta 2012)).
To implement the CHF guidelines in ASP, we first extensively studied the guidelines to extract
reasoning templates. These templates can be thought of as general knowledge patterns. These
patterns were next deployed to code the CHF guideline rules. Our research makes two major
contributions:
1. We develop a system that completely automates the entire set of guidelines for CHF man-
agement developed by the American College of Cardiology Foundation and American
Heart Association. The system takes its input from (i) a patient’s electronic health record
that includes demographic information, test results, etc., and (ii) a telemedicine system
that provides data about vital signs (heart rate, blood pressure, weight, etc.). It then uses
this information to recommend a treatment. The s(ASP) system also supports abduction,
thus our system can also be used for abductive reasoning: a physician can, for example,
figure out the symptoms that a particular patient must have in order for a given treatment
to work.
2. We develop a set of general knowledge patterns that were used to realize our automated
physician-advisory system and that can be helpful in translating rules expressed in a natural
language into ASP for any application domain.
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Table 1. Input of the Physician-Advisory System for CHF Management
Demographics Gender; age; race
Measurements Weight; creatinine; potassium; sinus rhythm; left bundle branch block;
non-left bundle branch block; QRS duration; ejection fraction
NYHA class; ACCF/AHA stage;
Diseases and Symptoms Sleep apnea, acute coronary syndrome; myocardial infarction; obesity;
diabetes; stroke; fluid retention; angioedema; ischemic attack;
thromboembolism; elevated plasma natriuretic peptide level;
asymptomatic ischemic cardiomyopathy; lipid disorders; hypertension;
atrial fibrillation; myocardial ischemia; coronary artery disease;
dilated cardiomyopathy; acute profound hemodynamic compromise;
threatened end organ dysfunction; ischemic heart disease;angina;
structural cardiac abnormalities; atrioventricular block; volume overload
Miscellany Expectation of survival;pregnancy; history of cardiovascular hospitalization;
history of standard neurohumoral antagonist therapy;
risk of cardioembolic stroke; eligibility of significant ventricular pacing;
eligibility of mechanical circulatory support;
dependence of continuous parenteral inotropic; ischemic etiology of HF;
requirement of ventricular pacing
3 A Physician-Advisory System for CHF Management
3.1 System Description
A large number of software systems have been designed to address CHF. However, none of them
are designed to automatically advise physicians based on the ACCF/AHA guidelines. Chronic
disease management systems designed thus far fall into seven categories (Jantos and Holmes 2006):
accessibility, care management, point-of-care functions, decision support, patient self-management,
population management, and reporting. The automation of these functionalities is certainly help-
ful in assisting health care providers with managing patients with chronic conditions, however,
none of them cover what we have realized: a physician advisory system that automates the ap-
plication of clinical practice guidelines. As mentioned earlier, our physician advisory system
for CHF management codes all the knowledge in the 2013 ACCF/AHA Guideline for the Man-
agement of Heart Failure (Yancy et al. 2013) as an answer set program. Our system is able to
recommend treatments just like a human physician who is strictly following these guidelines.
Additionally, our system is able to recommend treatments even when a patient’s information is
incomplete. The input to our system is the patient’s information which includes demographics,
history, daily symptoms, known risk factors, measurements as well as ACCF/AHA stage and
NYHA class (Yancy et al. 2013). The inputs to our system are summarized in Table 1. A physi-
cian uses our system by posing a query to it. Our system then processes the query by essentially
simulating the thinking process of a CHF specialist (represented by the ACCF/AHA guideline).
The physician-advisory system for CHF management has two major components, the rules
database and the fact table. The rules database covers all the knowledge in 2013 ACCF/AHA
Guideline for the Management of Heart Failure (Yancy et al. 2013). The fact table contains the
relevant information of the patient with heart failure. The fact table is derived from a patient’s
electronic health record and from a telemedicine system used to measure vital signs. The patient
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Table 2. Output of the Physician-Advisory System for CHF Management
Pharmaceutical Treatments ACE inhibitors; ARBs; Beta blockers; statin; diuretics;
aldosterone receptor antagonists; hydralazine and isosorbide dinitrate;
digoxin; anticoagulations; Omege-3 fatty acids; inotropes;
Management Objectives Systolic blood pressure control; diastolic blood pressure control;
obesity control; diabetes control; tobacco avoidance;
cardiotoxic agents avoidance; atrial fibrillation control; water restriction;
sodium restriction;
Device/Surgery Therapies Implantable cardioverter-defibrillator;
cardiac resynchronization therapy;
mechanical circulatory support; coronary revascularization
information consists mainly of: 5 pieces of demographics information, 8 measurements and 25
types of HF-related diseases and symptoms. Treatment recommendations returned by the sys-
tem may include: 11 pharmaceutical treatments, 9 management objectives, and 4 device/surgery
therapies. Table 2 displays the outputs produced by our system.
There are some sixty odd rules in the 2013 ACCF/AHA Guideline for the Management of
Heart Failure. All of these rules are coded in ASP to run on the s(ASP) system (Marple et al. 2016).
For example, take one rule from ACCF/AHA Stage B (Yancy et al. 2013):
“In all patients with a recent or remote history of MI or ACS and reduced EF, evidence-based beta
blockers should be used to reduce mortality.”
In s(ASP), this rule will be coded as shown below. Note that Prolog conventions are followed
(variables begin with an upper case letter).
recommendation(beta_blockers, class_1):- accf_stage(b),
history_of_mi_or_acs, measurement(lvef, Data),
reduced_ef(Data), not contraindication(beta_blockers).
Due to using ASP as the modeling formalism, our system is able to handle complex scenar-
ios. To illustrate this, consider a situation in which we have a patient who has heart failure with
reduced ejection fraction (HFrEF) and is in ACCF/AHA stage C. According to the guideline
(Yancy et al. 2013) our system would recommend the use of beta blockers. However, if we add
the information that the patient has a history of fluid retention, then our system would try to add
diuretics due to the following rule: “In patients with a current or recent history of fluid reten-
tion, beta blockers should not be prescribed without diuretics” (Yancy et al. 2013). However, if
diuretics are contraindicated for any reason, then our system will not recommend beta blockers
either. Our software system has been tested in-house and outputs found to be consistent with
our interpretation of the rules. More extensive testing and a clinical trial are planned in the near
future in collaboration with medical doctors who are CHF specialists.
Our system can also perform abductive reasoning thanks to the s(ASP) system’s support for
abduction (Marple et al. 2016). Abductive reasoning is a form of logical inference where one
attempts to augment a theory with sufficient information to explain an observation (the augmen-
tations come from a set of predicates that are declared as abducibles). To illustrate, consider the
following two rules in the ACCF/AHA guideline (Yancy et al. 2013):
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{accf stage(c), hf with reduced ef, history(standard neurohormonal antagonist therapy), nyha class(3),
nyha class 3 to 4, race(african american), recommendation(hydralazine and isosorbide dinitrate,class 1),
not contraindication(hydralazine and isosorbide dinitrate)}
Fig. 1. Result of abductive reasoning in physician-advisory system for CHF management
• Combination of hydralazine & isosorbide dinitrate is recommended to reduce morbidity &
mortality for patients self-described as African Americans with NYHA class III-IV HFrEF
receiving optimal therapy with ACE inhibitors & and beta blockers, unless contraindicated.
• Combination of hydralazine & isosorbide dinitrate should not be used for the treatment of
HFrEF in patients who have no prior use of standard neurohormonal antagonist therapy.
Suppose we have an African American patient who is suffering from NYHA class III HFrEF,
but that is all we know about the patient. Since a hydralazine and isosorbide dinitrate combination
is highly effective in reducing the mortality of African Americans with HFrEF, the physician
might pose the following query:
?-recommendation((hydralazine and isosorbide dinitrate), class 1)
to the s(ASP) system. The system would return the results shown in figure 1.
Note that the system abduced two things: (i) a “history of standard neurohormonal antagonist
therapy”, and (ii) the absence of “contraindication of hydralazine and isosorbide dinitrate”. This
means in order for us to recommend hydralazine and isosorbide dinitrate to the patient, they
must have received standard neurohormonal antagonist therapy before. Otherwise, hydralazine
and isosorbide dinitrate would be contraindicated.
3.2 Knowledge patterns in the guidelines for the management of heart failure
The ACCF/AHA guidelines are written in English and are quite complex. Our task was to code
these guidelines in ASP. To simplify our task, we developed reasoning templates that we call
knowledge patterns. These knowledge patterns are quite general and serve as solid building
blocks for systematically translating the specifications written in English to ASP. While develop-
ing these knowledge patterns and coding them in ASP, certain facts had to be noted: (i) Multiple
rules can lead to the recommendation of a treatment; (ii) Multiple rules can lead to contraindi-
cation of a treatment; (iii) A treatment cannot be recommended if at least one contraindication
for that treatment is present; and, (iv) A given treatment recommendation can impact the recom-
mendation and/or contraindication of other treatments.
Next, we present the most salient knowledge patterns that we have developed. Many of these
patterns are straightforward, however, some of them, such as the concomitant choice rule, are
intricate. We present these patterns at a high level and ignore non-essential details.
1. Aggressive Reasoning: The aggressive reasoning pattern can be stated as “take an action (e.g.,
recommend treatment) if there is a reason; no evidence of danger means there is no danger in
taking that action”. The aggressive reasoning pattern is coded as follows:
recommendation(Choice) :- preconditions(Choice),
not contraindication(Choice).
contraindication(Choice) :- dangers(Choice).
The code above makes use of negation as failure. If the contraindication of a choice cannot
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be proved, and the conditions for making the choice hold, then that choice is recommended.
An example of this knowledge pattern can be found in (Yancy et al. 2013): “Digoxin can be
beneficial in patients with HFrEF, unless contraindicated, to decrease hospitalizations for HF.” It
is realized in our system as shown below.
recommendation(digoxin, class_2a) :- not contraindication(digoxin),
accf_stage(c), hf_with_reduced_ef.
contraindication(digoxin) :- evidence(atrioventricular_block).
2. Conservative Reasoning: This reasoning pattern is stated as “A reason for a recommendation
is not enough; evidence that the recommendation is not harmful must be available”.
The conservative reasoning pattern is coded as follows:
recommendation(Choice) :- preconditions(Choice),
not contraindication(Choice).
contraindication(Choice) :- not -dangers(Choice).
This coding pattern requires evidence of the absence of danger. Without such evidence, the
choice would be considered contraindicated. Note that the “-” operator indicates classical nega-
tion. An example of this knowledge pattern can be found in (Yancy et al. 2013): “In patients with
structural cardiac abnormalities, including LV hypertrophy, in the absence of a history of MI
or ACS, blood pressure should be controlled in accordance with clinical practice guidelines for
hypertension to prevent symptomatic HF.” It is realized in our system as shown below.
recommendation(blood_pressure_control, class_1):-
accf_stage(b), diagnosis(structural_cardiac_abnormalities),
not contraindication(blood_pressure_control).
contraindication(blood_pressure_control):- not -history(mi).
contraindication(blood_pressure_control):- not -history(acs).
3. Anti-recommendation: The anti-recommendation pattern is stated as “a choice can be pro-
hibited if evidence of danger can be found”.
The coding pattern for the anti-recommendation is coded as follows:
contraindication(choice) :- dangers(Choice).
The code above specifies the conditions under which a choice will be ruled out (i.e., contraindi-
cated). Note that for a choice to be made, both aggressive reasoning and conservative reasoning
require that the contraindication of the choice be false. An example of this knowledge pattern can
be found in (Yancy et al. 2013): “Anticoagulation is not recommended in patients with chronic
HFrEF without AF, a prior thromboembolic event, or a cardioembolic source.” It is realized in
our system as shown below.
contraindication(anticoagulation) :- not cardioembolic_source,
not diagnosis(af), not history(thromboembolism),
hf_with_reduced_ef.
4. Preference: The preference pattern is stated as “use the second-line choice when the first-line
choice is not available”. The preference pattern is coded as follows:
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recommendation(First_choice) :- conditions_for_both_choices,
not contraindication(First_choice).
recommendation(Second_choice) :- conditions_for_both_choices,
contraindication(First_choice),
not contraindication(Second_choice).
This code chooses the treatment recommendation in the second choice only when the con-
ditions are satisfied, the first choice is contraindicated, and there is no evidence preventing the
use of second choice. An example of this knowledge pattern can be found in (Yancy et al. 2013):
“ARBs are recommended in patients with HFrEF with current or prior symptoms who are ACE
inhibitor intolerant, unless contraindicated, to reduce morbidity and mortality.” It is realized in
our system as shown below.
recommendation(ace_inhibitors, class_1) :-
not contraindication(ace_inhibitors),
accf_stage(c), hf_with_reduced_ef.
recommendation(arbs, class_1) :- contraindication(ace_inhibitors),
not contraindication(arbs),
not taboo_choice(arbs),
accf_stage(c), hf_with_reduced_ef.
5. Concomitant Choice: The concomitant choice pattern is stated as “if a choice is made, some
other choices are automatically in effect unless they are prohibited.” The concomitant pattern is
coded as shown below.
recommendation(Trigger_choice) :- preconditions(Trigger_choice),
not contraindication(Trigger_choice),
not skip_concomitant_choice(Trigger_choice).
skip_concomitant_choice(Trigger_choice) :-
not recommendation(Concomitant_choice),
not contraindication(Concomitant_choice).
recommendation(Concomitant_choice) :-
recommendation(Trigger_choice),
not contraindication(Concomitant_choice).
The above code makes sure that a concomitant choice appears in all stable models containing
the trigger choice, provided the concomitant choice is not prohibited. The trigger choice is always
recommended along with the concomitant choice unless the concomitant choice is contraindi-
cated. An example of this knowledge pattern can be found in (Yancy et al. 2013): “Diuretics
should generally be combined with an ACE inhibitor, beta blocker, and aldosterone antagonist.
Few patients with HF will be able to maintain target weight without the use of diuretics.” It is
realized in our system as shown below. To save space, we list only the code for ACE inhibitors.
recommendation(ace_inhibitors, class_1) :- accf_stage(c),
not skip_concomitant_choice(ace_inhibitors),
not contraindication(ace_inhibitors), hf_with_reduced_ef.
skip_concomitant_treatment(ace_inhibitors) :-
hf_with_reduced_ef, not recommendation(diuretics, class_1),
not contraindication(diuretics).
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recommendation(diuretics, class_1) :-
hf_with_reduced_ef, not contraindication(diuretics),
recommendation(ace_inhibitors, class_1).
6. Indispensable Choice: The indispensable choice pattern is stated as “if a choice is made, some
other choices must also be made; if those choices can’t be made, then the first choice is revoked”.
Note that choosing Trigger choice forces Indispensable choice. The indispensable choice pattern
is coded as shown below:
recommendation(Trigger_choice) :- preconditions(Trigger_choice),
not contraindication(Trigger_choice)
not absent_indispensable_choice(Trigger_choice).
absent_indispensable_choice(Trigger_choice) :-
not recommendation(Indispensable_choice).
recommendation(Indispensable_choice) :- recommendation(Trigger_choice),
not contraindication(Indispensable_choice).
The above code makes sure that the trigger choice will always appear with the indispensable
choice. If for some reason the indispensable choice cannot be made, then the trigger choice can-
not be made either. An example of this knowledge pattern can be found in (Yancy et al. 2013): “In
patients with a current or recent history of fluid retention, beta blockers should not be prescribed
without diuretics”. It is realized in our system as shown below.
recommendation(beta_blockers, class_1) :-
not skip_concomitant_choice(beta_blockers),
not absent_indispensable_choice(beta_blockers),
not contraindication(beta_blockers), accf_stage(c), hf_with_reduced_ef.
absent_indispensable_choice(beta_blockers) :-
not recommendation(diuretics, class_1), hf_with_reduced_ef,
accf_stage(c), current_or_recent_history_of_fluid_retention.
recommendation(diuretics, class_1) :-
recommendation(beta_blockers, class_1),
not contraindication(diuretics), accf_stage(c), hf_with_reduced_ef,
current_or_recent_history_of_fluid_retention.
7. Incompatible Choice: The incompatibility pattern is stated as “some choices cannot be in
effect at the same time”. The incompatible choice pattern is coded as shown below:
taboo_choice(Choice_1) :- recommendation(Choice_1) :-
recommendation(Choice_2), conditions_for_choice_1,
..., not contraindication(Choice_1),
recommendation(Choice_n). not taboo_choice(Choice_1).
taboo_choice(Choice_2) :- recommendation(Choice_2) :-
recommendation(Choice_1), conditions_for_choice_2,
recommendation(Choice_3), not contraindication(Choice_2),
.... not taboo_choice(Choice_2).
recommendation(Choice_n).
... ...
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taboo_choice(Choice_n) :- recommendation(Choice_n) :-
recommendation(Choice_1), conditions_for_choice_n,
recommendation(Choice_2), not contraindication(Choice_n),
.... not taboo_choice(Choice_n).
recommendation(Choice_n-1).
The above code makes sure that incompatible choices will not be made together. Note that we
did not use a simple constraint to implement this pattern. A constraint would kill all stable models
if each of the choices in question can be made. Our implementation, on the other hand, will
produce partial answer sets supporting the query, thanks to the goal-driven mechanism of s(ASP)
(Marple et al. 2016). An example of this knowledge pattern can be found in (Yancy et al. 2013):
“Routine combined use of an ACE inhibitor, ARB, and aldosterone antagonist is potentially
harmful for patients with HFrEF.” It is realized in our system as shown below.
taboo_choice(ace_inhibitors) :- hf_with_reduced_ef,
recommendation(arbs, class_1),
recommendation(aldosterone_antagonist, class_1).
taboo_choice(arbs) :- hf_with_reduced_ef,
recommendation(ace_inhibitors, class_1),
recommendation(aldosterone_antagonist, class_1).
taboo_choice(aldosterone_antagonist) :- hf_with_reduced_ef,
recommendation(arbs, class_1), recommendation(ace_inhibitors, class_1).
recommendation(ace_inhibitors, class_1) :- accf_stage(c),
hf_with_reduced_ef, not skip_concomitant_choice(ace_inhibitors),
not taboo_choice(ace_inhibitors), not contraindication(ace_inhibitors).
recommendation(arbs, class_1) :- contraindication(ace_inhibitors),
not contraindication(arbs), not taboo_choice(arbs),
accf_stage(c), hf_with_reduced_ef.
recommendation(aldosterone_antagonist, class_1) :-
conditions_for_aldosterone_antagonist_class_1,
not skip_concomitant_choice(aldosterone_antagonist),
not contraindication(aldosterone_antagonist),
not taboo_choice(aldosterone_antagonist).
4 Results and discussion
Our system has been tested in-house and has shown accurate results that are compatible with
what a physician following the guidelines would conclude. A clinical trial is planned.
To illustrate how our system works, consider a female heart failure patient who is in AC-
CF/AHA stage C, belongs to NYHA class 3 and has been diagnosed as myocardial ischemia,
atrial fibrillation, coronary artery disease. She also suffers from sleep apnea, fluid retention and
hypertension. Her left ventricular ejection fraction (LVEF) is 35%. There is evidence that she
has ischemic etiology of heart failure. Her electrocardiogram (ECG) has sinus rhythm and a left
bundle branch block (LBBB) pattern with a QRS duration of 180ms.The blood test says her cre-
atinine is 1.8 mg/dL and potassium is 4.9 mEg/L. She has a history of stroke. It has been 40 days
since the acute myocardial infarction happened to her. Her doctor assessed that her expectation
of survival is about 3 years.
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%doctor’s assessments %history of the patient
accf_stage(c). diagnosis(myocardial_ischemia).
nyha_class(3). diagnosis(atrial_fibrillation).
expectation_of_survival(3). diagnosis(coronary_artery_disease).
diagnosis(hypertension).
%demographics of the patient evidence(ischemic_etiology_of_hf).
gender(female). evidence(sleep_apnea).
age(78). evidence(fluid_retention).
history(mi, recent).
%measurements from the lab history(stroke).
hf_with_reduced_ef. history(cardiovascular_hospitalization).
measurement(creatinine, 1.8). post_mi(40).
measurement(potassium, 4.9).
measurement(lvef, 0.35).
measurement(lbbb, 180).
measurement(sinus_rhythm).
Fig. 2. Representation of a patient’s information in physician-advisory system for CHF manage-
ment
The patient’s information derived from her electronic health record is coded as the facts shown
in Figure 2. There are multiple treatments for this patient. Figure 3 shows some of the treatment
recommendations our system infers once we give the query recommendation(Treatment,
Class). Each treatment recommendation (represented as a partial answer set) contains all of
the predicates that must hold in order for the query to be successful. For instance, consider the
recommendation of ace inhibitors as a treatment option (answer #2). Ace inhibitors are recom-
mended because the patient is in ACCF/AHA Stage C, per the doctor’s assessment, and has heart
failure with reduced ejection fraction condition. Proof of contraindication for ace inhibitors is
absent as the patient does not have a history of angioedema (not history(angiodema)) and
is not pregnant (not pregnancy). The system also gives us the concomitant treatments for ace
inhibitors, namely, beta blockers and diuretics. It is worth mentioning that we used the aggres-
sive reasoning pattern (see section 3.2) when coding the rules of ace inhibitors. Had we adopted
the conservative reasoning pattern, ace inhibitors would not have been recommended unless we
explicitly asserted -history(angioedema) and -pregnancy in the patient’s information (a
definitive proof of the latter can be derived from patient’s age (78)).
Given that there may be multiple treatment options for a particular patient, the choice of a
particular treatment will depend on the physician’s preference. Rules that capture a physician’s
or a nurse’s preference can also be coded as answer set programs in our system.
While our testing indicates that the system works well and the results produced are consistent
with what a physician may recommend, if they were to exactly follow the guidelines, a clinical
trial is needed to truly validate our system, and is indeed planned. As mentioned earlier, our
system can be used for abductive reasoning as well. Running the system in the abductive mode
can allow a physician to try out what-if scenarios and to make sure that all the pre-conditions
required for treatment are met.
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{ accf stage(c), recommendation(sodium restriction,class 2a), not contraindication(sodium restriction) }
Treatment = sodium restriction, Class = class 2a
{ accf stage(c), hf with reduced ef, recommendation(ace inhibitors,class 1),
recommendation(beta blockers,class 1), recommendation(diuretics,class 1), not
contraindication(ace inhibitors), not contraindication(beta blockers), not contraindication(diuretics), not
history(angioedema), not history(angioedema,recent), not history(angioedema,remote), not pregnancy }
Treatment = ace inhibitors, Class = class 1
Fig. 3. Output of the physician-advisory system for CHF management
5 Conclusion and future work
In this paper we report on our work on developing a ASP-based physician advisory system for
managing CHF using a telemedicine platform. The system automates the rules laid out in the
2013 ACCF/AHA Guide for the Management of Heart Failure. It is able to take a patient’s data
as input and produce treatment recommendations that strictly adhere to the guidelines. It can also
be used by a physician to abduce symptoms and other conditions that must be met by a given
treatment recommendation.
Our approach to developing the system was based on identifying knowledge patterns and using
them as building blocks for constructing the ASP code. There are many ways to further extend
our work that we plan to pursue in the future:
• Extending the system for comorbidities: We would like our system to handle comorbidi-
ties of heart failure (Jantos and Holmes 2006). A typical CHF patients suffers from other
chronic ailments as well, i.e., CHF generally never occurs by itself.
• Performing clinical trials: our system has been tested in-house, however, we plan to com-
pare the recommendations given by our system to the prescriptions by human cardiologists
in a formal clinical trial to validate the effectiveness of our system.
• Integrating with EMRs and a Telemedicine Platform: Future work would include integrat-
ing our system with our telemedicine platform so that the input comes directly from the
electronic medical record while vital signs are directly obtained from the patient through
our telemedicine hardware and software (Monteiro et al. 2011; Monteiro 2015). A user-
friendly GUI will also be designed to make the system more usable.
• Adding justification to recommendations given by our system: Although the rationale be-
hind a recommendation is shown in the partial answer set, it is hard to decipher it. We
plan to augment s(ASP) (Marple et al. 2016) so that reasonably detailed justifications for
a query are printed in a human-readable form.
• Formal Analysis: Conducting research to formally establish the correctness of our system.
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